Funding

NGN-PET is supported by the IMI_JU with a financial contribution of € 1.5 million, which will be complemented by an in-kind contribution of € 1.8 million provided by the industrial partners. The project runs over three years until 31st March 2020.

NGN-PET is supported by over € 3.3 million funding from the Innovative Medicines Initiative 2 Joint Undertaking, under grant agreement No 116072. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA Companies. The project duration is 3 years.

Contact Information

Project Office/General Enquires
Project Leader: Xavier Codony , ESTEVE.
Project Coordinator: Dr. Paola Tarroni, Axxam SpA.